139 related articles for article (PubMed ID: 38211690)
21. Investigating the shared genetic architecture between primary sclerosing cholangitis and inflammatory bowel diseases: a Mendelian randomization study.
Dong X; Gong LL; Hong MZ; Pan JS
BMC Gastroenterol; 2024 Feb; 24(1):77. PubMed ID: 38373892
[TBL] [Abstract][Full Text] [Related]
22. Depression and Inflammatory Bowel Disease: A Bidirectional Two-sample Mendelian Randomization Study.
Luo J; Xu Z; Noordam R; van Heemst D; Li-Gao R
J Crohns Colitis; 2022 May; 16(4):633-642. PubMed ID: 34739073
[TBL] [Abstract][Full Text] [Related]
23. Association between inflammatory bowel disease and interleukins, chemokines: a two-sample bidirectional mendelian randomization study.
Fang G; Kong F; Zhang H; Huang B; Zhang J; Zhang X
Front Immunol; 2023; 14():1168188. PubMed ID: 37228614
[TBL] [Abstract][Full Text] [Related]
24. Risk relationship between inflammatory bowel disease and urolithiasis: A two-sample Mendelian randomization study.
Fu W; Zhu B; Chen J; Jin X
PLoS One; 2024; 19(4):e0301545. PubMed ID: 38593126
[TBL] [Abstract][Full Text] [Related]
25. Causal Association Between Inflammatory Bowel Disease and Psoriasis: A Two-Sample Bidirectional Mendelian Randomization Study.
Li Y; Guo J; Cao Z; Wu J
Front Immunol; 2022; 13():916645. PubMed ID: 35757704
[TBL] [Abstract][Full Text] [Related]
26. Inflammatory bowel disease and risk of autoimmune hepatitis: A univariable and multivariable Mendelian randomization study.
Chi G; Pei J; Li X
PLoS One; 2024; 19(6):e0305220. PubMed ID: 38848323
[TBL] [Abstract][Full Text] [Related]
27. Multi-omic insight into the molecular networks of mitochondrial dysfunction in the pathogenesis of inflammatory bowel disease.
Chen J; Ruan X; Sun Y; Lu S; Hu S; Yuan S; Li X
EBioMedicine; 2024 Jan; 99():104934. PubMed ID: 38103512
[TBL] [Abstract][Full Text] [Related]
28. Causal effects of inflammatory bowel diseases on the risk of kidney stone disease: a two-sample bidirectional mendelian randomization.
Zhang H; Huang Y; Zhang J; Su H; Ge C
BMC Urol; 2023 Oct; 23(1):162. PubMed ID: 37828486
[TBL] [Abstract][Full Text] [Related]
29. Type 2 diabetes and inflammatory bowel disease: a bidirectional two-sample Mendelian randomization study.
Xu G; Xu Y; Zheng T; Liu T
Sci Rep; 2024 Mar; 14(1):5149. PubMed ID: 38429331
[TBL] [Abstract][Full Text] [Related]
30. Association between systemic lupus erythematosus and inflammatory bowel disease in European and East Asian populations: a two-sample Mendelian randomization study.
Xie W; Jiang H; Chen Y; Zhang H; Song Y; Yu Z; Gu H; Xu H; Han S; Li S; Liu N; Han S
Front Immunol; 2023; 14():1199896. PubMed ID: 38022503
[TBL] [Abstract][Full Text] [Related]
31. Causal Association Between Atopic Dermatitis and Inflammatory Bowel Disease: A 2-Sample Bidirectional Mendelian Randomization Study.
Meisinger C; Freuer D
Inflamm Bowel Dis; 2022 Oct; 28(10):1543-1548. PubMed ID: 34964870
[TBL] [Abstract][Full Text] [Related]
32. Causal association between inflammatory bowel disease and hidradenitis suppurativa: A two-sample bidirectional Mendelian randomization study.
Bao B; Zhu C; Shi J; Lu C
Front Immunol; 2023; 14():1071616. PubMed ID: 36776852
[TBL] [Abstract][Full Text] [Related]
33. The causal effects of inflammatory bowel disease on primary biliary cholangitis: A bidirectional two-sample Mendelian randomization study.
Zhang H; Chen L; Fan Z; Lv G
Liver Int; 2023 Aug; 43(8):1741-1748. PubMed ID: 37283182
[TBL] [Abstract][Full Text] [Related]
34. The causal effect of inflammatory bowel disease on diffuse large B-cell lymphoma: two-sample Mendelian randomization study.
Lu C; Chen Q; Tao H; Xu L; Li J; Wang C; Yu L
Front Immunol; 2023; 14():1171446. PubMed ID: 37593734
[TBL] [Abstract][Full Text] [Related]
35. Immune-mediated inflammatory diseases and risk of venous thromboembolism: A Mendelian randomization study.
Lv X; Gao X; Liu J; Deng Y; Nie Q; Fan X; Ye Z; Liu P; Wen J
Front Immunol; 2022; 13():1042751. PubMed ID: 36582224
[TBL] [Abstract][Full Text] [Related]
36. Associations between sex hormones, receptors, binding proteins and inflammatory bowel disease: a Mendelian randomization study.
Zou F; Hu Y; Xu M; Wang S; Wu Z; Deng F
Front Endocrinol (Lausanne); 2024; 15():1272746. PubMed ID: 38660517
[TBL] [Abstract][Full Text] [Related]
37. The Effects of Fatty Acids on Inflammatory Bowel Disease: A Two-Sample Mendelian Randomization Study.
He J; Luo X; Xin H; Lai Q; Zhou Y; Bai Y
Nutrients; 2022 Jul; 14(14):. PubMed ID: 35889840
[TBL] [Abstract][Full Text] [Related]
38. Association between inflammatory bowel disease and cancer risk: evidence triangulation from genetic correlation, Mendelian randomization, and colocalization analyses across East Asian and European populations.
Liu D; Cao M; Wang H; Cao W; Zheng C; Li Y; Wang Y
BMC Med; 2024 Mar; 22(1):137. PubMed ID: 38528540
[TBL] [Abstract][Full Text] [Related]
39. Detecting potential causal relationship between inflammatory bowel disease and rosacea using bi-directional Mendelian randomization.
Li M; He SX; He YX; Hu XH; Zhou Z
Sci Rep; 2023 Sep; 13(1):14910. PubMed ID: 37689807
[TBL] [Abstract][Full Text] [Related]
40. Mendelian randomization analysis reveals causal associations of inflammatory bowel disease with Spondylarthritis.
Wang M; He X
Gene; 2024 Apr; 902():148170. PubMed ID: 38237812
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
